Open original FDA record ↗Recall record
- FDA identifier
- Z-0066-2015
- Company in FDA record
- Arrow International Inc
- FDA classification date
- Oct 14, 2014
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The component supplier recalled their 0.9% Sodium Chloride Injection USP BD Posiflush SF Saline Flush Syringe 10mL because some unit packages may exhibit open seals which impact package integrity and potentially product sterility.
Source facts
- Action
- Arrow International sent an Urgent Medical Device Recall Notification letter, dated August 6, 2014, to all affected customers. The letter identified the product, the problem, and the action to be taken by the customer. Customers were instructed to immediately discontinue use and quarantine any affected product. Customers were instructed to remove the BD pre-filled saline syringe from the exterior of the packaging. To return the BD syringes, customers were instructed to complete the enclosed Recall Acknowledgement Form and fax it to 1-855-419-8507, Attn: Customer Service. A customer service representative will contact the customer with a Return Good Authorization (RGA) Number and will provide instructions for the return of producet to Arrow International. All customers were asked to complete the enclosed Recall Acknowledgement Form and fax it to 1-855-419-8507. Attn: Customer Service. Customers with questions were instructed to contact their local sales representative or Customer Service at 1-866-246-6990.
- Initiated
- 2014-08-06
- Root cause
- Packaging
- Terminated
- 2016-10-14
- Distribution
- Nationwide Distribution
- Recall number
- Z-0066-2015
- Recall status
- Terminated
- CDRH record ID
- 129204
- FDA classified
- 2014-10-14
- Recall event number
- 68987